Compare WEAV & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEAV | MLAB |
|---|---|---|
| Founded | 2011 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.7M | 442.0M |
| IPO Year | 2021 | 1995 |
| Metric | WEAV | MLAB |
|---|---|---|
| Price | $4.75 | $82.51 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | $11.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 1.7M | 115.8K |
| Earning Date | 05-04-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | 7.50 | ★ 99.24 |
| EPS | N/A | ★ 1.95 |
| Revenue | ★ $239,024,000.00 | N/A |
| Revenue This Year | $17.20 | $6.07 |
| Revenue Next Year | $13.74 | $5.41 |
| P/E Ratio | ★ N/A | $41.03 |
| Revenue Growth | ★ 16.99 | N/A |
| 52 Week Low | $4.60 | $59.63 |
| 52 Week High | $12.17 | $128.55 |
| Indicator | WEAV | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 33.48 | 46.13 |
| Support Level | N/A | $69.73 |
| Resistance Level | $7.31 | $89.69 |
| Average True Range (ATR) | 0.26 | 3.99 |
| MACD | 0.01 | -0.44 |
| Stochastic Oscillator | 15.18 | 49.03 |
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.